Impact of rat P450 genetic polymorphism on diazepam metabolism

Bibliography

• Sachidanandam R, Weissman D, Schmidt SC, A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001;409:928-33
   PubMed Web of Science ®Google Scholar
• Nebert DW, Russell DW. Clinical importance of the cytochromes P450. Lancet 2002;360(9340):1155-62
   PubMed Web of Science ®Google Scholar
• Goldstein JA. Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol 2001;52(4):349-55
   PubMed Web of Science ®Google Scholar
• Cascorbi I. Pharmacogenetics of cytochrome p4502D6: genetic background and clinical implication. Eur J Clin Invest 2003;33(Suppl 2):17-22
   PubMedGoogle Scholar
• Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 2005;5(1):6-13
   PubMed Web of Science ®Google Scholar
• Zanger UM, Raimundo S, Eichelbaum M. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch Pharmacol 2004;369(1):23-37
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ, Vilbois F, Hardwick JP, Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22. Genomics 1988;2(2):174-9
   PubMedGoogle Scholar
• Available from: http://www.imm.ki.se/CYPalleles/cyp2d6.htm
   Google Scholar
• Gonzalez FJ, Matsunaga T, Nagata K, Debrisoquine 4-hydroxylase: characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism. DNA 1987;6(2):149-61
   PubMedGoogle Scholar
• Boobis AR, Seddon CE, Davies DS. Bufuralol 1′-hydroxylase activity of the rat. Strain differences and the effects of inhibitors. Biochem Pharmacol 1986;35(17):2961-5
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Tasaki T, Nakamura A, Molecular basis of the Dark Agouti rat drug oxidation polymorphism: importance of CYP2D1 and CYP2D2. Pharmacogenetics 1998;8(1):73-82
   PubMedGoogle Scholar
• Colado MI, Williams JL, Green AR. The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype. Br J Pharmacol 1995;115(7):1281-9
   PubMed Web of Science ®Google Scholar
• Stresser DM, Turner SD, Blanchard AP, Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab Dispos 2002;30(7):845-52
   PubMed Web of Science ®Google Scholar
• Guentert TW. Pharmacokinetics of benzodiazepines and of their metabolites. Prog Drug Metab 1984;8:241-386
   Google Scholar
• Klotz U, Antonin KH, Bieck PR. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. J Pharmacol Exp Ther 1976;199(1):67-73
   PubMed Web of Science ®Google Scholar
• Eatman FB, Colburn WA, Boxenbaum HG, Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects. J Pharmacokinet Biopharm 1977;5(5):481-94
   PubMedGoogle Scholar
• Seddon T, Michelle I, Chenery RJ. Comparative drug metabolism of diazepam in hepatocytes isolated from man, rat, monkey and dog. Biochem Pharmacol 1989;38(10):1657-65
   PubMed Web of Science ®Google Scholar
• Fujita S, Chiba M, Ohta M, Alteration of plasma sex hormone levels associated with old age and its effect on hepatic drug metabolism in rats. J Pharmacol Exp Ther 1990;253(1):369-74
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Harmatz JS, Shader RI. Factors influencing diazepam pharmacokinetics: age, sex, and liver disease. Int J Clin Pharmacol Biopharm 1978;16(4):177-9
   PubMedGoogle Scholar
• Ohnhaus EE, Park BK, Colombo JP, The effect of enzyme induction on diazepam metabolism in man. Br J Clin Pharmacol 1979;8(6):557-63
   PubMed Web of Science ®Google Scholar
• Ohnhaus EE, Brockmeyer N, Dylewicz P, The effect of antipyrine and rifampin on the metabolism of diazepam. Clin Pharmacol Ther 1987;42(2):148-56
   PubMed Web of Science ®Google Scholar
• Klotz U, Reimann I. Delayed clearance of diazepam due to cimetidine. N Engl J Med 1980;302(18):1012-4
   PubMed Web of Science ®Google Scholar
• Bertilsson L, Henthorn TK, Sanz E, Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype. Clin Pharmacol Ther 1989;45(4):348-55
   PubMed Web of Science ®Google Scholar
• Boxenbaum H. Comparative pharmacokinetics of benzodiazepines in dog and man. J Pharmacokinet Biopharm 1982;10(4):411-26
   PubMedGoogle Scholar
• Jack ML, Colburn WA. Pharmacokinetic model for diazepam and its major metabolite desmethyldiazepam following diazepam administration. J Pharm Sci 1983;72(11):1318-23
   PubMed Web of Science ®Google Scholar
• Bertilsson L, Baillie TA, Reviriego J. Factors influencing the metabolism of diazepam. Pharmacol Ther 1990;45(1):85-91
   PubMed Web of Science ®Google Scholar
• Kanto J, Sellman R, Haataja M, Plasma and urine concentrations of diazepam and its metabolites in children, adults and in diazepam-intoxicated patients. Int J Clin Pharmacol Biopharm 1978;16(6):258-64
   PubMedGoogle Scholar
• Yasumori T, Nagata K, Yang SK, Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner. Pharmacogenetics 1993;3(6):291-301
   PubMedGoogle Scholar
• Andersson T, Miners JO, Veronese ME, Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. Br J Clin Pharmacol 1994;38(2):131-7
   PubMed Web of Science ®Google Scholar
• Jung F, Richardson TH, Raucy JL, Diazepam metabolism by cDNA-expressed human 2C P450s: identification of P4502C18 and P4502C19 as low K(M) diazepam N-demethylases. Drug Metab Dispos 1997;25(2):133-9
   PubMed Web of Science ®Google Scholar
• Yang TJ, Shou M, Korzekwa KR, Role of cDNA-expressed human cytochromes P450 in the metabolism of diazepam. Biochem Pharmacol 1998;55(6):889-96
   PubMed Web of Science ®Google Scholar
• Wrighton SA, Stevens JC, Becker GW, Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4′-hydroxylation. Arch Biochem Biophys 1993;306(1):240-5
   PubMed Web of Science ®Google Scholar
• Goldstein JA, Faletto MB, Romkes-Sparks M, Evidence that CYP2C19 is the major (S)-mephenytoin 4′-hydroxylase in humans. Biochemistry 1994;33(7):1743-52
   PubMed Web of Science ®Google Scholar
• Yang TJ, Krausz KW, Sai Y, Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism. Drug Metab Dispos 1999;27(1):102-9
   PubMed Web of Science ®Google Scholar
• McManus ME, Burgess WM, Veronese ME, Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res 1990;50(11):3367-76
   PubMed Web of Science ®Google Scholar
• Chenery RJ, Ayrton A, Oldham HG, Diazepam metabolism in cultured hepatocytes from rat, rabbit, dog, guinea pig, and man. Drug Metab Dispos 1987;15(3):312-7
   PubMed Web of Science ®Google Scholar
• Andrews SM, Griffiths LA. The metabolism and disposition of [2-14C] diazepam in the streptozotocin-diabetic rat. Xenobiotica 1984;14(10):751-60
   PubMed Web of Science ®Google Scholar
• Zomorodi K, Carlile DJ, Houston JB. Kinetics of diazepam metabolism in rat hepatic microsomes and hepatocytes and their use in predicting in vivo hepatic clearance. Xenobiotica 1995;25(9):907-16
   PubMed Web of Science ®Google Scholar
• Saito K, Kim HS, Sakai N, Polymorphism in diazepam metabolism in Wistar rats. J Pharm Sci 2004;93(5):1271-8
   PubMed Web of Science ®Google Scholar
• Saito K, Sakai N, Kim HS, Strain differences in diazepam metabolism at its three metabolic sites in sprague-dawley, brown norway, dark agouti, and wistar strain rats. Drug Metab Dispos 2004;32(9):959-65
   PubMed Web of Science ®Google Scholar
• Jauregui HO, Ng SF, Gann KL, Xenobiotic induction of P-450 PB-4 (IIB1) and P-450c (IA1) and associated monooxygenase activities in primary cultures of adult rat hepatocytes. Xenobiotica 1991;21(9):1091-106
   PubMed Web of Science ®Google Scholar
• Reilly PE, Thompson DA, Mason SR, Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam. Mol Pharmacol 1990;37(5):767-74
   PubMed Web of Science ®Google Scholar
• Neville CF, Ninomiya S, Shimada N, Characterization of specific cytochrome P450 enzymes responsible for the metabolism of diazepam in hepatic microsomes of adult male rats. Biochem Pharmacol 1993;45(1):59-65
   PubMed Web of Science ®Google Scholar
• Waxman DJ. Rat hepatic cytochrome P-450 isoenzyme 2c. Identification as a male-specific, developmentally induced steroid 16 alpha-hydroxylase and comparison to a female-specific cytochrome P-450 isoenzyme. J Biol Chem 1984;259(24):15481-90
   PubMedGoogle Scholar
• Gonzalez FJ, Song BJ, Hardwick JP. Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation. Mol Cell Biol 1986;6(8):2969-76
   PubMed Web of Science ®Google Scholar
• Chow T, Imaoka S, Hiroi T, Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver. Drug Metab Dispos 1999;27(2):188-92
   PubMed Web of Science ®Google Scholar
• Sakai N, Saito K, Kim HS, Importance of CYP2D3 in polymorphism of diazepam p-hydroxylation in rats. Drug Metab Dispos 2005;33(11):1657-60
   PubMed Web of Science ®Google Scholar
• Matsunaga E, Gonzalez FJ. Specific cytosine demethylations within the first exons of the rat CYP2D3 and CYP2D5 genes are associated with activation of hepatic gene expression during development. DNA Cell Biol 1990;9(6):443-52
   PubMed Web of Science ®Google Scholar
• Matsunaga E, Zanger UM, Hardwick JP, The CYP2D gene subfamily: analysis of the molecular basis of the debrisoquine 4-hydroxylase deficiency in DA rats. Biochemistry 1989;28(18):7349-55
   PubMed Web of Science ®Google Scholar
• St-Pierre MV, Pang KS. Concentration-dependent metabolism of diazepam in mouse liver. J Pharmacokinet Biopharm 1995;23(3):243-66
   PubMedGoogle Scholar
• Schwartz MA, Koechlin BA, Postma E, Metabolism of diazepam in rat, dog, and man. J Pharmacol Exp Ther 1965;149(3):423-35
   PubMed Web of Science ®Google Scholar
• Coutinho CB, Cheripko JA, Carbone JJ, Behavioural changes in primates and diazepam metabolism. Xenobiotica 1973;3(10):681-90
   PubMed Web of Science ®Google Scholar
• Seddon T, Lockwood GF, Chenery RJ. In vitro drug metabolism and pharmacokinetics of diazepam in cynomolgus monkey hepatocytes during culture for six days. Biochem Pharmacol 1989;38(16):2621-30
   PubMed Web of Science ®Google Scholar
• Jommi G, Manitto P, Silanos MA. Metabolism of diazepam in rabbits. Arch Biochem Biophys 1964;108:562-8
   PubMed Web of Science ®Google Scholar
• Inaba T, Tait A, Nakano M, Metabolism of diazepam in vitro by human liver. Independent variability of N-demethylation and C3-hydroxylation. Drug Metab Dispos 1988;16(4):605-8
   PubMed Web of Science ®Google Scholar
• Bertilsson L. Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet 1995;29(3):192-209
   PubMed Web of Science ®Google Scholar
• Sohn DR, Kusaka M, Ishizaki T, Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics. Clin Pharmacol Ther 1992;52(2):160-9
   PubMed Web of Science ®Google Scholar
• Andersson T, Regardh CG, Dahl-Puustinen ML, Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators. Ther Drug Monit 1990;12(4):415-6
   PubMed Web of Science ®Google Scholar
• Zhang YA, Reviriego J, Lou YQ, Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin: interethnic differences in comparison with white subjects. Clin Pharmacol Ther 1990;48(5):496-502
   PubMed Web of Science ®Google Scholar
• Bertilsson L, Kalow W. Why are diazepam metabolism and polymorphic S-mephenytoin hydroxylation associated with each other in white and Korean populations but not in Chinese populations? Clin Pharmacol Ther 1993;53(5):608-10
   PubMed Web of Science ®Google Scholar
• Qin XP, Xie HG, Wang W, Effect of the gene dosage of CgammaP2C19 on diazepam metabolism in Chinese subjects. Clin Pharmacol Ther 1999;66(6):642-6
   PubMed Web of Science ®Google Scholar
• Wan J, Xia H, He N, The elimination of diazepam in Chinese subjects is dependent on the mephenytoin oxidation phenotype. Br J Clin Pharmacol 1996;42(4):471-4
   PubMed Web of Science ®Google Scholar
• Ghoneim MM, Korttila K, Chiang CK, Diazepam effects and kinetics in Caucasians and Orientals. Clin Pharmacol Ther 1981;29(6):749-56
   PubMed Web of Science ®Google Scholar
• Desta Z, Zhao X, Shin JG, Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin Pharmacokinet 2002;41(12):913-58
   PubMed Web of Science ®Google Scholar
• Inomata S, Nagashima A, Itagaki F, CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia. Clin Pharmacol Ther 2005;78(6):647-55
   PubMed Web of Science ®Google Scholar
• Gallaher EJ, Hollister LE, Gionet SE, Mouse lines selected for genetic differences in diazepam sensitivity. Psychopharmacology (Berl) 1987;93(1):25-30
   PubMed Web of Science ®Google Scholar
• Wilks L, File SE, Martin IL. Evidence of strain differences in GABA-benzodiazepine coupling. Psychopharmacology (Berl) 1987;93(1):127-32
   PubMed Web of Science ®Google Scholar
• Griebel G, Belzung C, Perrault G, Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology (Berl) 2000;148(2):164-70
   PubMed Web of Science ®Google Scholar
• Robertson HA, Martin IL, Candy JM. Differences in benzodiazepine receptor binding in Maudsley reactive and Maudsley non-reactive rats. Eur J Pharmacol 1978;50(4):455-7
   PubMed Web of Science ®Google Scholar
• Shephard RA, Nielsen EB, Broadhurst PL. Sex and strain differences in benzodiazepine receptor binding in Roman rat strains. Eur J Pharmacol 1982;77(4):327-30
   PubMed Web of Science ®Google Scholar
• Van der Laan JW, de Boer SF, Van der Gugten J, Differences in the duration of sedative and anxiolytic effects of desmethyldiazepam in two outbred Wistar strains. Pharmacol Biochem Behav 1991;39(1):149-53
   PubMed Web of Science ®Google Scholar
• Van der Laan JW, de Groot G, Wortelboer H, Pharmacokinetic differences of desmethyldiazepam in three outbred Wistar strains related to differences in liver enzyme activities. Pharmacol Toxicol 1993;73(4):229-32
   PubMedGoogle Scholar
• Bert B, Fink H, Sohr R, Different effects of diazepam in Fischer rats and two stocks of Wistar rats in tests of anxiety. Pharmacol Biochem Behav 2001;70(2-3):411-20
   PubMed Web of Science ®Google Scholar
• Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 1996;54(1):21-30
   PubMed Web of Science ®Google Scholar
• Ramos A, Berton O, Mormede P, A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res 1997;85(1):57-69
   PubMed Web of Science ®Google Scholar
• Mechan AO, Moran PM, Elliott M, A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam. Psychopharmacology (Berl) 2002;159(2):188-95
   PubMed Web of Science ®Google Scholar
• Al-Dabbagh SG, Idle JR, Smith RL. Animal modelling of human polymorphic drug oxidation–the metabolism of debrisoquine and phenacetin in rat inbred strains. J Pharm Pharmacol 1981;33(3):161-4
   PubMed Web of Science ®Google Scholar
• Schulz-Utermoehl T, Bennett AJ, Ellis SW, Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression. Pharmacogenetics 1999;9(3):357-66
   PubMedGoogle Scholar
• Pellow S, Chopin P, File SE, Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985;14(3):149-67
   PubMed Web of Science ®Google Scholar
• File SE, Zangrossi H Jr. “One-trial tolerance” to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology (Berl) 1993;110(1-2):240-4
   PubMed Web of Science ®Google Scholar
• Morita K, Maeda Y, Masuda M, Strain differences in CYP3A-mediated C-8 hydroxylation (1,3,7-trimethyluric acid formation) of caffeine in Wistar and Dark Agouti rats. Rapid metabolism of caffeine in debrisoquine poor metabolizer model rats. Biochem Pharmacol 1998;55(9):1405-11
   PubMed Web of Science ®Google Scholar
• Lopez-Rubalcava C. Pre- or postsynaptic activity of 5-HT1A compounds in mice depends on the anxiety paradigm. Pharmacol Biochem Behav 1996;54(4):677-86
   PubMed Web of Science ®Google Scholar
• Liebsch G, Linthorst AC, Neumann ID, Behavioral, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high- and low-anxiety-related behavior. Neuropsychopharmacology 1998;19(5):381-96
   PubMed Web of Science ®Google Scholar
• Wan J, Imaoka S, Chow T, Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity. Arch Biochem Biophys 1997;348(2):383-90
   PubMed Web of Science ®Google Scholar
• Masubuchi Y, Umeda S, Chiba M, Selective 3-hydroxylation deficiency of lidocaine and its metabolite in Dark Agouti rats. Biochem Pharmacol 1991;42(3):693-5
   PubMed Web of Science ®Google Scholar
• Masubuchi Y, Umeda S, Igarashi S, Participation of the CYP2D subfamily in lidocaine 3-hydroxylation and formation of a reactive metabolite covalently bound to liver microsomal protein in rats. Biochem Pharmacol 1993;46(10):1867-9
   PubMed Web of Science ®Google Scholar
• Carcillo JA, Parise RA, Adedoyin A, CYP2D6 mRNA expression in circulating peripheral blood mononuclear cells correlates with in vivo debrisoquine hydroxylase activity in extensive metabolizers. Res Commun Mol Pathol Pharmacol 1996;91(2):149-59
   PubMed Web of Science ®Google Scholar
• Romkes-Sparks M, Mnuskin A, Chern HD, Correlation of polymorphic expression of CYP2D6 mRNA in bladder mucosa and tumor tissue to in vivo debrisoquine hydroxylase activity. Carcinogenesis 1994;15(9):1955-61
   PubMed Web of Science ®Google Scholar
• Sakai N, Saito K, Sakamoto KQ, Genetic basis of inter- and intrastrain differences in diazepam p-hydroxylation in rats. Drug Metab Dispos 2009;37(2):268-71
   PubMed Web of Science ®Google Scholar
• Maquat LE. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol 2004;5(2):89-99
   PubMed Web of Science ®Google Scholar
• Endrizzi K, Fischer J, Klein K, Discriminative quantification of cytochrome P4502D6 and 2D7/8 pseudogene expression by TaqMan real-time reverse transcriptase polymerase chain reaction. Anal Biochem 2002;300(2):121-31
   PubMed Web of Science ®Google Scholar
• Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics 2002;3(2):229-43
   PubMed Web of Science ®Google Scholar
• Kuehl P, Zhang J, Lin Y, Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 2001;27(4):383-91
   PubMed Web of Science ®Google Scholar
• Busi F, Cresteil T. CYP3A5 mRNA degradation by nonsense-mediated mRNA decay. Mol Pharmacol 2005;68(3):808-15
   PubMed Web of Science ®Google Scholar
• Okamoto K, Yamori Y, Ooshima A, Establishment of the inbred strain of the spontaneously hypertensive rat and genetic factors involved in hypertension. In spontaneous hypertension: its pathogenesis and complicatioins: Tokyo: Igaku Shoin, 1972 . p. 1-8
   Google Scholar
• Landgraf R, Wigger A. High vs low anxiety-related behavior rats: an animal model of extremes in trait anxiety. Behav Genet 2002;32(5):301-14
   PubMed Web of Science ®Google Scholar
• Muller JR, Le KM, Haines WR, Hemodynamic response pattern predicts susceptibility to stress-induced elevation in arterial pressure in the rat. Am J Physiol Regul Integr Comp Physiol 2001;281(1):R31-7
   PubMed Web of Science ®Google Scholar
• Fedrowitz M, Kamino K, Loscher W. Significant differences in the effects of magnetic field exposure on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in two substrains of Sprague-Dawley rats. Cancer Res 2004;64(1):243-51
   PubMed Web of Science ®Google Scholar